Published in J Control Release on October 01, 2011
Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting. J Drug Deliv (2013) 1.06
Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo. Int J Nanomedicine (2013) 0.78
Self-assembled liposomal nanoparticles in photodynamic therapy. Eur J Nanomed (2013) 0.78
Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2017) 0.77
Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future. Lasers Med Sci (2015) 0.76
Polymeric nanocarrier systems for photodynamic therapy. Biomater Res (2014) 0.76
Design features for optimization of tetrapyrrole macrocycles as antimicrobial and anticancer photosensitizers. Chem Biol Drug Des (2017) 0.75
Photonanomedicine: a convergence of photodynamic therapy and nanotechnology. Nanoscale (2016) 0.75
Photodynamic Physiology-Photonanomanipulations in Cellular Physiology with Protein Photosensitizers. Front Physiol (2017) 0.75
A Targeted Nanoprobe Based on Carbon Nanotubes-Natural Biopolymer Chitosan Composites. Nanomaterials (Basel) (2016) 0.75
Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer. Br J Cancer (2016) 0.75
The role of nitric oxide in cancer. Cell Res (2002) 2.38
Efficacy of the specific endothelin a receptor antagonist zibotentan (ZD4054) in colorectal cancer: a preclinical study. Mol Cancer Ther (2013) 2.05
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci (2009) 1.98
Spectroscopic sensing of cancer and cancer therapy: current status of translational research. Cancer Biol Ther (2004) 1.55
Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol (2002) 1.51
3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal (2011) 1.47
Interstitial laser photocoagulation for uterine myomas. Am J Obstet Gynecol (2002) 1.40
Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique. Gastrointest Endosc (2006) 1.31
Virtual reality training for surgical trainees in laparoscopic surgery. Cochrane Database Syst Rev (2013) 1.23
Elastic scattering spectroscopy for intraoperative determination of sentinel lymph node status in the breast. J Biomed Opt (2004) 1.13
Toxicology and clinical potential of nanoparticles. Nano Today (2011) 1.05
Endothelin-1 and angiogenesis in cancer. Curr Vasc Pharmacol (2005) 1.03
Photochemical internalisation of a macromolecular protein toxin using a cell penetrating peptide-photosensitiser conjugate. J Control Release (2011) 0.98
Photodynamic therapy using verteporfin photosensitization in the pancreas and surrounding tissues in the Syrian golden hamster. Pancreatology (2007) 0.96
Endothelin-1 stimulates colon cancer adjacent fibroblasts. Int J Cancer (2011) 0.96
Elastic scattering spectroscopy for detection of cancer risk in Barrett's esophagus: experimental and clinical validation of error removal by orthogonal subtraction for increasing accuracy. J Biomed Opt (2009) 0.96
Scanning elastic scattering spectroscopy detects metastatic breast cancer in sentinel lymph nodes. J Biomed Opt (2010) 0.95
Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin. Eur J Gastroenterol Hepatol (2007) 0.94
Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization. Int J Cancer (2006) 0.92
The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry. Photochem Photobiol Sci (2007) 0.92
Oxygen diffusion through collagen scaffolds at defined densities: implications for cell survival in tissue models. J Tissue Eng Regen Med (2011) 0.91
A novel tissue engineered three-dimensional in vitro colorectal cancer model. Acta Biomater (2013) 0.91
Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Release (2007) 0.90
Photodynamic therapy for pancreatic and biliary tract carcinoma. Int J Gastrointest Cancer (2005) 0.89
Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. Gastrointest Endosc (2005) 0.88
Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br J Pharmacol (2006) 0.85
Evidence for intracellular aggregation of hypericin and the impact on its photocytotoxicity in PAM 212 murine keratinocytes. Photochem Photobiol (2004) 0.85
Photochemical internalization of therapeutic macromolecular agents: a novel strategy to kill multidrug-resistant cancer cells. J Pharmacol Exp Ther (2006) 0.85
Altered endothelin receptor subtypes in colorectal cancer. Eur J Gastroenterol Hepatol (2007) 0.84
Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy. Lasers Med Sci (2008) 0.84
Effective photoinactivation of Gram-positive and Gram-negative bacterial strains using an HIV-1 Tat peptide-porphyrin conjugate. Photochem Photobiol Sci (2010) 0.84
How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus. Lasers Med Sci (2007) 0.83
Palliation of patients with dysphagia due to advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gel. Gastrointest Endosc (2002) 0.83
Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine (Lond) (2010) 0.81
Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer? BJU Int (2005) 0.81
Photodynamic therapy with WST09 (Tookad): quantitative studies in normal colon and transplanted tumours. Int J Cancer (2006) 0.81
Photophysical and photobiological properties of a sulfonated chlorin photosensitiser TPCS(2a) for photochemical internalisation (PCI). Photochem Photobiol Sci (2012) 0.81
Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies. Colloids Surf B Biointerfaces (2008) 0.80
Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy. Int J Biochem Cell Biol (2005) 0.80
Intracellular re-localisation by photochemical internalisation enhances the cytotoxic effect of gelonin--quantitative studies in normal rat liver. J Control Release (2009) 0.80
Quantitative determination of 5-aminolaevulinic acid and its esters in cell lysates by HPLC-fluorescence. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.80
Organic nanocarriers for cancer drug delivery. Curr Opin Pharmacol (2012) 0.80
A novel phospholipid-binding protein from the yeast Saccharomyces cerevisiae with dual binding specificities for the transport GTPase Ypt7p and the Sec1-related Vps33p. Eur J Cell Biol (2002) 0.80
Light penetration in the human prostate: a whole prostate clinical study at 763 nm. J Biomed Opt (2011) 0.80
Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra(hydroxyphenyl)chlorin (m-THPC). Photochem Photobiol Sci (2013) 0.79
The vascular response to photodynamic therapy with ATX-S10Na(II) in the normal rat colon. J Photochem Photobiol B (2005) 0.79
Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid. Lasers Surg Med (2006) 0.79
CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy. Phys Med Biol (2014) 0.78
Development of liposomes containing ethanol for skin delivery of temoporfin: characterization and in vitro penetration studies. Colloids Surf B Biointerfaces (2009) 0.78
Assessment of fluidity of different invasomes by electron spin resonance and differential scanning calorimetry. Int J Pharm (2011) 0.78
In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy. Nanomedicine (Lond) (2012) 0.78
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems. Nanoscale (2013) 0.77
Detection of cell surface calreticulin as a potential cancer biomarker using near-infrared emitting gold nanoclusters. Nanotechnology (2016) 0.77
Meta-tetra(hydroxyphenyl)chlorin-loaded liposomes sterically stabilised with poly(ethylene glycol) of different length and density: characterisation, in vitro cellular uptake and phototoxicity. Photochem Photobiol Sci (2011) 0.77
Monitoring the effect of PDT on in vivo oxygen saturation and microvascular circulation. Adv Exp Med Biol (2003) 0.77
Photodynamic modification of disulfonated aluminium phthalocyanine fluorescence in a macrophage cell line. Photochem Photobiol Sci (2007) 0.76
Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease. Lasers Surg Med (2011) 0.76
A 3D in vitro cancer model as a platform for nanoparticle uptake and imaging investigations. Small (2014) 0.75
Determination of cell-specific receptor binding using a combination of immunohistochemistry and in vitro autoradiography: relevance to therapeutic receptor targeting in cancer. Methods Mol Biol (2012) 0.75
Towards the small and the beautiful: smart targeting and smart technologies for novel cancer treatments. Curr Opin Pharmacol (2012) 0.75